Clinical Trials Browser

Interventional × Recurrence × plerixafor × Clear all

NCT00903968 2020-06-02

Combination Plerixafor (AMD3100)and Bortezomib in Relapsed or Relapsed/Refractory Multiple Myeloma

Phase 1/2 Completed

58 enrolled 13 charts

Multiple Myeloma, Recurrence

NCT01319864 2018-09-07

POETIC Plerixafor as a Chemosensitizing Agent for Relapsed Acute Leukemia and MDS in Pediatric Patients

Phase 1 Completed

Other hematologic neoplasm

Leukemia, Recurrence, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute

NCT01655875 2014-04-07

BMTAMD3100

Phase 1 Terminated

LymphoidOther hematologic neoplasm

Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma